A review of current and promising nontuberculous mycobacteria antibiotics.

Future Medicinal Chemistry
Christophe R CantelliPascal Sonnet

Abstract

Nontuberculous mycobacteria infections are a growing concern, and their incidence has been increasing worldwide in recent years. Current treatments are not necessarily useful because many were initially designed to work against other bacteria, such as Mycobacterium tuberculosis. In addition, inadequate treatment means that resistant strains are increasingly appearing, particularly for Mycobacterium abscessus, one of the most virulent nontuberculous mycobacteria. There is an urgent need to develop new antibiotics specifically directed against these nontuberculous mycobacteria. To help in this fight against the emergence of these pathogens, this review describes the most promising heterocyclic antibiotics under development, with particular attention paid to their structure-activity relationships.

References

Jul 1, 1983·Reviews of Infectious Diseases·W Wehrli
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·A E BelangerJ M Inamine
Oct 10, 2002·Clinics in Chest Medicine·Joseph O Falkinham
Apr 1, 2003·Archiv der Pharmazie·Karel WaisserJarmila Kaustová
Aug 17, 2004·Infectious Disease Clinics of North America·Jerry M Zuckerman
Feb 11, 2005·Chemical Reviews·Leonard Katz, Gary W Ashley
Jun 23, 2006·Infectious Disorders Drug Targets·Timothy D H BuggDavid I Roper
Jan 24, 2007·Antimicrobial Agents and Chemotherapy·Michael J PucciMilind Deshpande
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Dec 12, 2007·Antimicrobial Agents and Chemotherapy·Venkata M ReddyCarol A Nacy
Mar 7, 2008·Bioorganic & Medicinal Chemistry·Gemma TriolaHerbert Waldmann
Sep 22, 2009·The Journal of Infection·Donald C Vinh, Ethan Rubinstein
Mar 17, 2010·Antimicrobial Agents and Chemotherapy·Carmen A Molina-TorresLucio Vera-Cabrera
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Ji-Woong JeongJin-Hwan Kwak
Oct 19, 2010·The Journal of Antimicrobial Chemotherapy·Tia DubuissonVenkata M Reddy
Apr 6, 2011·Antimicrobial Agents and Chemotherapy·Michael J PucciMilind Deshpande
Dec 14, 2011·Journal of Medicinal Chemistry·Roger B ClarkXiao-Yi Xiao
Feb 1, 2012·The Journal of Antimicrobial Chemotherapy·Rachid NessarBrigitte Gicquel
Feb 9, 2012·American Journal of Respiratory and Critical Care Medicine·Jennifer AdjemianD Rebecca Prevots
Feb 14, 2012·Expert Opinion on Investigational Drugs·Zeina A Kanafani, G Ralph Corey
Apr 25, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jakko van IngenJohan W Mouton
May 16, 2012·Antimicrobial Agents and Chemotherapy·Michael CynamonTrudy H Grossman
May 23, 2012·Antimicrobial Agents and Chemotherapy·Vincent DubéeMichel Arthur
Jan 12, 2013·ChemMedChem·Lluís BallellNicholas Cammack
Apr 20, 2013·The European Respiratory Journal·Wouter HoefslootUNKNOWN Nontuberculous Mycobacteria Network European Trials Group
Oct 17, 2013·Indian Journal of Pharmacology·Shashank Deoghare
Oct 23, 2013·Antimicrobial Agents and Chemotherapy·Boris NikonenkoCarol A Nacy
Dec 18, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Martin KrátkýJiřina Stolaříková

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT04550832
NCT04553406
NCT02968212
NCT03038178
NCT01315236
NCT03220074

Software Mentioned

CS ChemOffice Ultra

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatrics in Review
P Joan Chesney
The New Zealand Medical Journal
B C Parker, J O Falkinham
Deutsches Ärzteblatt International
Norbert HeinrichElvira Richter
Respiratory Medicine
J G Scadding
Canadian Respiratory Journal : Journal of the Canadian Thoracic Society
Nick R Anthonisen
© 2021 Meta ULC. All rights reserved